Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

e2v secures ?18.3m contract renewal

9th Mar 2009 07:00

RNS Number : 4898O
e2v technologies PLC
09 March 2009
 



9th March 2009

e2v technologies plc

e2v secures £18.3m contract renewal

e2v technologies, a specialist developer and manufacturer of high technology components and sub-systems, announces it has secured a contract renewal worth £18.3m.

e2v will supply products from its electron device and sub-systems division, for incorporation into linear accelerators for radiotherapy cancer treatment machines, to an existing Original Equipment Manufacturer (OEM) customer. 

e2v's electron devices generate and deliver the microwave power required by radiotherapy cancer treatment machines to produce the X-rays used in the imaging and radiation treatment of tumours, and are for both new equipment and the ongoing service and support of installed systems.

Deliveries will commence immediately and be completed over a 3 year period.

Keith Attwood, Chief Executive of e2v said: "This contract renewal helps underpin trading performance for the current year and beyond, reinforcing our strong position in this market."

For further information:

e2v technologies plc

Tel: +44 (0)1245 493493

Keith Attwood/Mike Hannant

www.e2v.com

Financial Dynamics

Tel: +44 (0)20 7269 7225

Jon Simmons/Sophie Kernon

   

NOTES FOR EDITORS

e2v 

e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical and science, aerospace and defence, and commercial and industrial markets.

e2v has 4 major product groups:

High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, and radar systems

Advanced Imaging sensors and cameras for applications including industrial process control, dental X-ray systems, space science and life sciences

Specialist semiconductors, including logic, memory and microprocessors for high reliability mission-critical programs in avionics, defence and telecommunications, sensor data acquisition, and high speed data conversion

A range of professional sensing products for applications including fire, rescue and security thermal imaging, X-ray spectroscopy, and military surveillance, targeting and guidance

For the year ended 31 March 2008, e2v achieved sales of £205m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. 

The Company is headquartered in the United Kingdom and has approximately 1800 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.

Further information is available from www.e2v.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTQQLFBKXBZBBL

Related Shares:

E2V.L
FTSE 100 Latest
Value8,837.91
Change26.87